ResearcherThe University of SydneyActive in the last 2 years
Mark Wong
Matched on ORCID iD 0000-0003-4242-025X; OpenAlex author ID A5103845787, A5105525046. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- Impact of postoperative pancreatic fistula (POPF) on long-term outcomes of patients who underwent pancreatic cancer resection: systematic review and meta-analy… Co-author DOI 10.1016/j.suronc.2026.102459↗
- Biomarker Analysis from Patients with Metastatic PDAC Treated with TGFβ Antibody NIS793 plus Abraxane + Gemcitabine versus Abraxane + Gemcitabine Alone in a Ph… Co-author DOI 10.1158/1078-0432.ccr-26-0805↗
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, rand… Last author DOI 10.1016/s0140-6736(15)00986-1↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lee S. Kyang · 1 shared paper, 2026 · strength 0.26
- Vincent W. T. Lam · 1 shared paper, 2026 · strength 0.26
- Henry C. C. Pleass · 1 shared paper, 2026 · strength 0.26
- Adnan M. Nagrial · 1 shared paper, 2026 · strength 0.26
- Christopher Bahdah Nahm · 1 shared paper, 2026 · strength 0.26
- Tony Pang · 1 shared paper, 2026 · strength 0.26
- Viviana Cremasco · 1 shared paper, 2026 · strength 0.20
- Marc R. Pelletier · 1 shared paper, 2026 · strength 0.20
- Li‐Yuan Bai · 1 shared paper, 2026 · strength 0.20
- Michèle Milella · 1 shared paper, 2026 · strength 0.20
- David Wai-Meng Tai · 1 shared paper, 2026 · strength 0.20
- Bruno Bockorny · 1 shared paper, 2026 · strength 0.20
- Gerald W. Prager · 1 shared paper, 2026 · strength 0.20
- Shivan Sivakumar · 1 shared paper, 2026 · strength 0.20
- Teresa Mercade Macarulla · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.